Prime Medicine IncNASDAQ:PRME
- LAST PRICE21.1100
- TODAY'S CHANGE (%)1.1100 (5.5500%)
- Bid / Lots20.3000/ 1
- Ask / Lots21.5000/ 10
- Open / Previous Close19.7900 / 20.0000
- Day Range
- 52 Week Range
- Volume439,993
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRME |
|---|---|---|
| 09:32 ET | 1245 | 19.75 |
| 09:33 ET | 2490 | 20.28 |
| 09:35 ET | 21278 | 20.57 |
| 09:37 ET | 23100 | 20.83 |
| 09:39 ET | 6747 | 21.03 |
| 09:42 ET | 6034 | 20.99 |
| 09:44 ET | 57707 | 21.475 |
| 09:46 ET | 2000 | 20.66 |
| 09:48 ET | 100 | 21.13 |
| 09:50 ET | 3886 | 20.655 |
| 09:51 ET | 600 | 20.65 |
| 09:53 ET | 1967 | 20.8795 |
| 09:55 ET | 722 | 21 |
| 09:57 ET | 800 | 21.2 |
| 10:00 ET | 100 | 21.22 |
| 10:02 ET | 5835 | 20.935 |
| 10:04 ET | 200 | 20.75 |
| 10:06 ET | 2847 | 20.95 |
| 10:08 ET | 1300 | 20.855 |
| 10:11 ET | 164 | 20.71 |
| 10:13 ET | 200 | 20.535 |
| 10:15 ET | 283 | 20.6511 |
| 10:18 ET | 3600 | 20.85 |
| 10:20 ET | 300 | 20.52 |
| 10:22 ET | 4400 | 20.415 |
| 10:24 ET | 8798 | 20.475 |
| 10:26 ET | 15272 | 20.54 |
| 10:27 ET | 500 | 20.37 |
| 10:29 ET | 300 | 20.165 |
| 10:31 ET | 1761 | 20.255 |
| 10:36 ET | 800 | 20.315 |
| 10:45 ET | 900 | 20.36 |
| 10:49 ET | 1400 | 20.63 |
| 10:51 ET | 200 | 20.595 |
| 10:56 ET | 100 | 20.71 |
| 10:58 ET | 700 | 20.71 |
| 11:03 ET | 100 | 20.82 |
| 11:05 ET | 100 | 20.65 |
| 11:07 ET | 200 | 20.825 |
| 11:12 ET | 200 | 20.745 |
| 11:16 ET | 1206 | 21 |
| 11:18 ET | 600 | 20.85 |
| 11:20 ET | 1100 | 21 |
| 11:21 ET | 1100 | 20.95 |
| 11:23 ET | 1565 | 21.1 |
| 11:25 ET | 1000 | 21.01 |
| 11:27 ET | 1499 | 20.97 |
| 11:30 ET | 7200 | 20.88 |
| 11:32 ET | 300 | 20.74 |
| 11:38 ET | 400 | 20.88 |
| 11:39 ET | 4366 | 21.01 |
| 11:41 ET | 500 | 21.07 |
| 11:48 ET | 254 | 21.0907 |
| 11:52 ET | 13160 | 20.75 |
| 11:56 ET | 400 | 20.74 |
| 11:57 ET | 600 | 20.675 |
| 11:59 ET | 100 | 20.66 |
| 12:01 ET | 100 | 20.54 |
| 12:03 ET | 100 | 20.565 |
| 12:08 ET | 313 | 20.585 |
| 12:12 ET | 1000 | 20.62 |
| 12:14 ET | 100 | 20.7 |
| 12:15 ET | 215 | 20.7 |
| 12:17 ET | 300 | 20.58 |
| 12:24 ET | 6941 | 20.82 |
| 12:26 ET | 900 | 20.77 |
| 12:28 ET | 1000 | 20.94 |
| 12:30 ET | 200 | 20.8 |
| 12:33 ET | 100 | 20.875 |
| 12:37 ET | 100 | 20.885 |
| 12:42 ET | 314 | 20.885 |
| 12:44 ET | 1300 | 20.755 |
| 12:46 ET | 300 | 20.65 |
| 12:48 ET | 1675 | 20.665 |
| 12:51 ET | 100 | 20.7 |
| 12:53 ET | 4963 | 20.7 |
| 12:55 ET | 3301 | 20.66 |
| 12:57 ET | 4883 | 20.69 |
| 01:00 ET | 1566 | 20.66 |
| 01:02 ET | 2818 | 20.63 |
| 01:04 ET | 300 | 20.49 |
| 01:06 ET | 7044 | 20.55 |
| 01:08 ET | 100 | 20.59 |
| 01:13 ET | 400 | 20.59 |
| 01:15 ET | 100 | 20.5 |
| 01:18 ET | 800 | 20.5 |
| 01:20 ET | 166 | 20.53 |
| 01:22 ET | 100 | 20.55 |
| 01:24 ET | 500 | 20.5349 |
| 01:27 ET | 600 | 20.62 |
| 01:31 ET | 100 | 20.72 |
| 01:33 ET | 100 | 20.66 |
| 01:36 ET | 100 | 20.72 |
| 01:38 ET | 850 | 20.73 |
| 01:40 ET | 500 | 20.605 |
| 01:42 ET | 1416 | 20.73 |
| 01:44 ET | 137 | 20.675 |
| 01:47 ET | 3009 | 20.62 |
| 01:49 ET | 8711 | 20.7531 |
| 01:51 ET | 200 | 20.765 |
| 01:54 ET | 300 | 20.8 |
| 01:56 ET | 3700 | 20.98 |
| 01:58 ET | 700 | 20.995 |
| 02:00 ET | 200 | 21.055 |
| 02:02 ET | 620 | 20.975 |
| 02:03 ET | 2645 | 21.09 |
| 02:05 ET | 5308 | 21.05 |
| 02:07 ET | 1100 | 21.05 |
| 02:09 ET | 757 | 21.065 |
| 02:12 ET | 200 | 21.01 |
| 02:16 ET | 1900 | 21.15 |
| 02:18 ET | 300 | 21.195 |
| 02:20 ET | 2700 | 21.02 |
| 02:21 ET | 100 | 21.02 |
| 02:25 ET | 100 | 21.055 |
| 02:27 ET | 100 | 21.11 |
| 02:30 ET | 700 | 21.13 |
| 02:32 ET | 600 | 21.11 |
| 02:34 ET | 1000 | 21.08 |
| 02:36 ET | 200 | 21.08 |
| 02:38 ET | 1000 | 21.16 |
| 02:43 ET | 1234 | 21.13 |
| 02:45 ET | 300 | 21.19 |
| 02:48 ET | 100 | 21.135 |
| 02:50 ET | 1000 | 21.08 |
| 02:52 ET | 400 | 21.08 |
| 02:54 ET | 112 | 21.0679 |
| 02:56 ET | 700 | 21.15 |
| 02:57 ET | 300 | 21.15 |
| 02:59 ET | 1500 | 21.19 |
| 03:01 ET | 300 | 21.2 |
| 03:03 ET | 1609 | 21.23 |
| 03:06 ET | 2875 | 21.24 |
| 03:08 ET | 1500 | 21.085 |
| 03:10 ET | 700 | 21.16 |
| 03:12 ET | 700 | 21.145 |
| 03:14 ET | 18350 | 21.25 |
| 03:15 ET | 2006 | 21.25 |
| 03:17 ET | 697 | 21.185 |
| 03:19 ET | 1900 | 21.2 |
| 03:21 ET | 4100 | 21.17 |
| 03:26 ET | 200 | 21.22 |
| 03:28 ET | 300 | 21.22 |
| 03:30 ET | 100 | 21.25 |
| 03:32 ET | 585 | 21.25 |
| 03:35 ET | 300 | 21.25 |
| 03:39 ET | 300 | 21.23 |
| 03:42 ET | 2708 | 21.185 |
| 03:44 ET | 254 | 21.19 |
| 03:46 ET | 1200 | 21.13 |
| 03:48 ET | 100 | 21.185 |
| 03:50 ET | 17409 | 20.89 |
| 03:51 ET | 900 | 20.955 |
| 03:53 ET | 1894 | 21.08 |
| 03:55 ET | 4549 | 21.1199 |
| 03:57 ET | 6305 | 21.14 |
| 04:00 ET | 3350 | 21.11 |
Jan 24, 2023
--Morgan Stanley Adjusts Price Target on Prime Medicine to $21 From $23, Maintains Equal-Weight Rating, from 11:41AM ET on Tuesday Jan 24, 2023 by MT Newswires
11:41AM ET on Tuesday Jan 24, 2023 by MT Newswires
Jan 9, 2023
BRIEF-Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities, from 8:12AM ET on Monday Jan 09, 2023 by Thomson Reuters
8:12AM ET on Monday Jan 09, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prime Medicine Inc | 2.1B | -11.7x | --- |
Krystal Biotech Inc | 2.1B | -15.4x | --- |
SpringWorks Therapeutics Inc | 2.0B | -6.1x | --- |
Celldex Therapeutics Inc | 2.2B | -20.3x | --- |
Akero Therapeutics Inc | 2.2B | -14.2x | --- |
Immunovant Inc | 2.3B | -10.7x | --- |
Company Information
Prime Medicine, Inc. is a United States-based biotechnology company. The Company is engaged in multiple drug discovery programs that target liver, eye, ex-vivo hematopoietic stem cell and neuro-muscular indications. The Company's Prime Editing, a transformative technology that addressed the cause of genetic disease. The Company's collaborative approach help fight disease and accelerating the development of Prime Editing to deliver therapies for patients. Its Prime Editing is used to modify gene-regulatory sequences. These edits can be made in therapeutically relevant cells and organs, including specialized terminally differentiated cells. Its Prime Editing acts as a Deoxyribonucleic acid (DNA) word processor, with the power to search and replace genetic sequences at their exact location in the genome, all without making double-strand breaks in DNA.
Contact Information
- Headquarters
- 21 Erie StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-465-0013
- Fax
- 302-655-5049
Executives
- President, Chief Executive Officer, Director
- Keith Gottesdiener
- Co-Founder
- David Liu
- Chief Financial Officer, Chief Accounting Officer
- Carman Alenson
- Senior Vice President, Strategy, Corporate Operations
- Meredith Goldwasser
- Chief Technical Officer
- Ann Lee
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 97.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.81 |
Book Value | $2.50 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
